Stock comparison
Haemonetics
UFP Technologies
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
UFPT
UFP Technologies
Market cap
$1.77B
Sector
Healthcare
Overall winner
UFP Technologies UFPT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | UFPT | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 64C | HAE |
| Benjamin Graham | 85A | 79B | HAE |
| Philip Fisher | 60C | 64C | UFPT |
| Peter Lynch | 54C | 62C | UFPT |
| Joel Greenblatt | 31F | 43D | UFPT |
| Charlie Munger | 54D | 50C | HAE |
| Terry Smith | 55D | 52D | HAE |
Side-by-side metrics
| Metric | HAE | UFPT |
|---|---|---|
| Market cap | $2.98B | $1.77B |
| P/E (TTM) | 24.8x | 24.4x |
| EV/EBIT | 14.1x | 19.7x |
| ROIC (TTM) | 8.37% | 12.31% |
| Gross margin | 55.74% | 28.35% |
| Net margin | 7.29% | 11.27% |
| Revenue CAGR 5y | 7.65% | 30.74% |
| EPS CAGR 5y | 24.62% | 43.19% |
| Debt / Equity | 1.5x | 0.4x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- Gross margin55.74%vs 28.35%+49%
- Market cap$2.98Bvs $1.77B+40%
- EV/EBIT14.1xvs 19.7x+28%
UFPT leads on
- Debt / Equity0.4xvs 1.5x+77%
- Revenue CAGR 5y30.74%vs 7.65%+75%
- EPS CAGR 5y43.19%vs 24.62%+43%
- Net margin11.27%vs 7.29%+35%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.